RegMed Investors’ (RMi) closing bell analysis, up today …

January 25, 2017 6:58pm

… As the oversold finally reaped the notice of being under valuated

The market soars to a major milestone as “our” universe only skips to a trading beat

… Sector moves aren’t what they used to be  

Pre-open indication’s tally:  4 hit (AGTC, AST, BLFS, IMUC and VCEL) and 2 miss (BSTG and ONCE)

I answer one question; in which company should investors put, keep and commit their money!

… As I focus on the facts in evidence …

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.

U.S. equities closed at all-time highs on Wednesday after a series of executive orders from President Trump increased bullish sentiment on the “street”.

The NASDAQ closed UP +55.38 or +0.99% to 5,656.34 and the DOW closed UP +155.80 or +0.78% to 20,068.51.

A day in the life of the stem, cell, gene and regenerative therapy (SCGT & RT) sector – the advance/decline line scenario of our 43 covered companies:   

• The open was positive with an A/DL of 22/18 and 3 flats;
• The mid-day stayed positive with an A/DL of 28/13 and 2 flats;
• The closing bell continued positive with A/DL of 28/12 and 3 flats;

Henry’omics:

From the mid-day’s investor’s letter, “Some want to build wall and they could be needed however, I want to … tear down the wall between investors and managements. Many of their hype creators and the lawyers who want to include themselves in every transaction need to be … billed if they contributed to a depreciating share pricing …”

• As I stated, “More communication can juice share pricing or the usual response we have nothing to say about a stagnant or dwindling share price. All the king's horses and men … and PR flacks and hacks still can't seem to put a “sustainable and appreciating” release together”

Traders waded in after I positive session  and 5 negative closes … who would make that bet … momentum was on trader’s side.

• I believe there is nothing more to it …

However, investors should look out for a potential pullback from these levels by Friday; who wants to be long over a weekend and any twitter barrage!

Indexes, the ebb and flow:

• The iShares Russell 2000 (IWM) indicated a positive +0.49% in the pre- open and closed UP +1.53%.
• The iShares NASDAQ Biotechnology (IBB) indicated a positive +0.70% in the pre-open and closed DOWN -0.84%

Pre-open indication’s tally:  4 hit (AGTC, AST, BLFS, IMUC and VCEL) and 2 miss (BSTG and ONCE)

• Applied Genetic Technologies (AGTC) closed UP +$0.25 – hit;
• Asterias Biosciences (NYSEMKT: AST) closed DOWN -0.25 – hit;
• BioLife Solutions (BLFS) closed DOWN -$0.03 – hit;
• Biostage (BSTG) closed UP +$0.046 – miss;
• ImmunoCellular (NYSEMKT: IMUC) closed DOWN -$0.20 – hit
• Spark Therapeutics (ONCE) closed UP +$0.13 – miss;
• Vericel (VCEL) closed FLAT $0.00 – hit;

Today’s 5 top dollar gainers included:

• Kite (KITE) +$0.79 after Tuesday’s +2.07 after Monday’s -$1.30 after Friday’s -$0.42 after last Thursday’s +$0.05;
• Spark Therapeutics (ONCE) +$0.76 after Monday’s +$0.39 after Friday’s +$1.23;
• Juno Therapeutics (JUNO) +0.22
• Bellicum (BLCM) +40.32;
• Stemline (STML) +$0.25;

Today’s 5 largest dollar losers of the session were:

• Intrexon (XON) -$0.51 after Tuesday’s -$0.44 after Monday’s -$1.22;
• Asterias Biosciences (NYSEMKT: AST) -$0.25;
• ImmunoCellular (NYSEMKT: IMUC) -$0.20 after Tuesday’s +$0.368;
• AxoGen (AXGN) -$0.10 after Tuesday’s FLAT at $10.10;
• Verastem (VSTM) -$0.05

Flat:

• Aduro Biotech (ADRO) at $11.15;
• Sangamo (SGMO) at $3.60;
• Vericel VCEL) at $2.70                                                              

The downside trend reflects a pricing trend range of:

• Wednesday’s decliners ranged from -0.30% <BTX> to -7.444% <IMUC> in 12 equities;
• Tuesday’s decliners ranged from -0.44% <CAPR> to -3.57% <AGTC> in 15 equities;
• Monday’s decliners ranged from -0.08% <BLUE> to -10.46% <FATE> in 25 equities;
• Friday’s decliners ranged from -0.25% <MDXG> to -17.86% <PSTI> in 26 equities;
• Thursday’s decliners ranged from -0.20% <OSIR> to -6.71% <HSGX> in 32 equities;
• Last Wednesday’s decliners ranged from -0.01% <BSTG> to -7.99% <ISCO> in 22 equities;

The upside shows a pricing trend range of:

• Wednesday’s gainers ranged from +0.22% <ONCE> to +10.49% <FCSC> in 28 equities;
• Tuesday’s gainers ranged from +0.35% <KOOL> to +14.78% <IMUC> in 26 equities;
• Monday’s gainers ranged from +0.55% <ONCE> to +5.07% <KOOL> in 13 equities;
• Friday’s gainers ranged from +0.31% <CAPR> to +14% <ISCO> in 15 equities;
• Thursday’s gainers ranged from +0.11% <KITE> to +8.68% <ISCO> in 8 equities;
• Last Wednesday’s gainers ranged from +0.06% <CLLS> to +10.74% <NWBO> in 17 equities;

The week’s beginning:

• Wednesday’s 28 gainers followed Tuesday’s 26, Monday’s 13, Friday’s 15, Thursday’s 8 and last Wednesday’s 17
• Wednesday’s 12 decliners followed Tuesday’s 15, Monday’s 25, Friday’s 26, Thursday’s 32, Wednesday’s 22 and last Tuesday’s 38

Review my fear gauge or the CBOE Volatility Index (VIX):

·         Wednesday traded near 10.8;

·         Tuesday traded near 11.4;

·         Monday traded near 12.2;

·         Friday traded near 12.3;

·         Thursday traded near 12.4;

·         Last Wednesday traded near 12.44;

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.